Research examining human cardiac samples has revealed several key findings: GLP-1R mRNA transcripts have been consistently detected in all four cardiac chambers from human hearts, at levels approximating those in human pancreas [1] Receptor expression is notably absent in cardiac fibroblasts, coronary artery endothelial cells, and vascular smooth muscle cells according to some studies [1] Human GLP-1R expression appears predominantly in cardiomyocytes, albeit at relatively low levels [2] Interestingly, species differences exist in GLP-1R distribution patterns
National Library of Medicine.
Individual results vary and are not guaranteed
A link is provided to refer ASO (self-funded) clients to the CMS site for their required next steps
If you know someone with asthma youll have heard of Ventolin or similar
In November 2024, the Biden administration introduced a proposal to expand Medicare and Medicaid coverage of GLP-1s to treat obesity as a condition on its own, which would expand access for millions of beneficiaries
